My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
SU0004749 SSCRPT
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
S
>
STAMPEDE
>
19260
>
2600 - Land Use Program
>
PA-0400744
>
SU0004749 SSCRPT
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/7/2020 11:31:11 AM
Creation date
9/9/2019 10:19:26 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2600 - Land Use Program
FileName_PostFix
SSCRPT
RECORD_ID
SU0004749
PE
2622
FACILITY_NAME
PA-0400744
STREET_NUMBER
19260
Direction
E
STREET_NAME
STAMPEDE
STREET_TYPE
RD
City
CLEMENTS
APN
01934004, 05
ENTERED_DATE
12/16/2004 12:00:00 AM
SITE_LOCATION
19260 E STAMPEDE RD
RECEIVED_DATE
12/15/2004 12:00:00 AM
P_LOCATION
99
P_DISTRICT
004
QC Status
Approved
Scanner
SJGOV\rtan
Supplemental fields
FilePath
\MIGRATIONS\S\STAMPEDE\19260\PA-0400744\SU0004749\SSC RPT.PDF
Tags
EHD - Public
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
49
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
EXTOXNET PIP - IMIDACLOPRID Page 2 of 4 <br /> ,*.e %000 <br /> (223), and 131 mg/kg in mice (1). The 24-hour dermal LD50 in rats is >5,000 mg/kg. It is <br /> considered non-irritating to eyes and skin (rabbits), and non-sensitizing to skin (guinea pigs) (1). <br /> Some granular formulations may contain clays as inert ingredients that may act as eye irritants. In <br /> acute inhalation toxicity tests with rats, the airborne concentration of imidacloprid that resulted in <br /> mortality to half of the test organisms (LC50) is> 69 mg/meters cubed air in the form of an <br /> aerosol, and>5323 mg/meters cubed air in the form of dust. These values represent the maximum <br /> attainable airborne concentrations (1). <br /> • Signs and Symptoms of Poisoning: Although no account of human poisoning was found in the <br /> literature, signs and symptoms of poisoning would be expected to be similar to nicotinic signs and <br /> symptoms, including fatigue, twitching, cramps, and muscle weakness including the muscles <br /> necessary for breathing (330). <br /> • Chronic Toxicity: A 2-year feeding study in rats fed up to 1,800 ppm resulted in a No <br /> Observable Effect Level (NOEL) of 100 ppm (5.7 mg/kg body weight in males and 7.6 mg/kg in <br /> females). Adverse effects included decreased body weight gain in females at 300 ppm, and <br /> increased thyroid lesions in males at 300 ppm and females at 900 ppm. A 1-year feeding study in <br /> dogs fed up to 2,500 ppm resulted in a NOEL of 1,250 ppm (41 mg/kg). Adverse effects included <br /> increased cholesterol levels in the blood, and some stress to the liver(measured by elevated liver <br /> cytochrome p-450 levels) (331). <br /> • Reproductive Effects: A three generation reproduction study in rats fed up to 700 ppm <br /> imidacloprid resulted in a NOEL of 100 ppm (equivalent to 8 mg/kg/day) based on decreased pup <br /> body weight observed at the 250 ppm dose level (331). <br /> • Teratogenic Effects: A developmental toxicity study in rats given doses up to 100 ppm by <br /> gavage on days 6 to 16 of gestation resulted in a NOEL of 30 mg/kg/day (based on skeletal <br /> abnormalities observed at the next highest dose tested of 100 ppm) (329). In a developmental <br /> toxicity study with rabbits given doses of imidacloprid by gavage during days 6 through 19 of <br /> gestation, resulted in a NOEL of 24 mg/kg/day based on decreased body weight and skeletal <br /> abnormalities observed at 72 mg/kg/day (highest dose tested) (331). <br /> • Mutagenic Effects: Imidacloprid may be weakly mutagenic. In a battery of 23 laboratory <br /> mutagenicity assays, imidacloprid tested negative for mutagenic effects in all but two of the <br /> assays. It did test positive for causing changes in chromosomes in human lymphocytes, as well as <br /> testing positive for genotoxicity in Chinese hamster ovary cells (331). <br /> • Carcinogenic Effects: Imidacloprid is considered to be of minimal carcinogenic risk, and is thus <br /> categorized by EPA as a "Group E" carcinogen (evidence of noncarcinogenicity for humans). <br /> There were no carcinogenic effects in a 2-year carcinogenicity study in rats fed up to 1,800 ppm <br /> imidacloprid (328). <br /> • Organ Toxicity: In short-term feeding studies in rats, there were thyroid lesions associated with <br /> very high doses of imidacloprid (331). <br /> • Fate in Humans and Animals: Imidacloprid is quickly and almost completely absorbed from the <br /> gastrointestinal tract, and eliminated via urine and feces (70-80% and 20-30%, respectively, of the <br /> 96% of the parent compound administered within 48 hours). The most important metabolic steps <br /> include the degradation to 6-chloronicotinic acid, a compound that acts on the nervous system as <br /> described above. This compound may be conjugated with glycine and eliminated, or reduced to <br /> guanidine (1). <br /> ECOLOGICAL EFFECTS <br /> • Effects on Birds: Imidacloprid is toxic to upland game birds. The LD50 is 152 mg/kg for <br /> bobwhite quail, and 31 mg/kg in Japanese quail (223, 1). In studies with red-winged blackbirds <br /> and brown-headed cowbirds, it was observed that birds learned to avoid imidacloprid treated seeds <br /> after experiencing transitory gastrointestinal distress (retching) and ataxia(loss of coordination). It <br /> was concluded that the risk of dietary exposure to birds via treated seeds was minimal. Based on <br /> http://extoxnet.orst.edu/pips/imidaclo.htm 11/22/2004 <br />
The URL can be used to link to this page
Your browser does not support the video tag.